Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
213K
-
Shares change
-
+88.9K
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
+$5.35M
-
Number of buys
-
4
-
Price
-
$60.17
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q4 2023
5 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q4 2023.
Legend Biotech Corp - COMMON STOCK (LEGN) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213K shares
of 367M outstanding shares and own 0.06% of the company stock.
Largest 10 shareholders include FMR LLC (12.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), RA CAPITAL MANAGEMENT, L.P. (6.26M shares), HHLR ADVISORS, LTD. (5.98M shares), BlackRock Inc. (5.27M shares), Capital World Investors (2.39M shares), WELLINGTON MANAGEMENT GROUP LLP (2.31M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.98M shares), Paradigm Biocapital Advisors LP (1.89M shares), and JANUS HENDERSON GROUP PLC (1.87M shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.